Cited by 887Neuropeptides and Animal PhysiologyStress Responses and CortisolNeuroendocrine regulation and behavior

Urocortin II: A Member of the Corticotropin-Releasing Factor (CRF) Neuropeptide Family that Is Selectively Bound by Type 2 CRF Receptors

Open access
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J. +3 more·2001·Proceedings of the National Academy of Sciences

Abstract

Here we describe the cloning and initial characterization of a previously unidentified CRF-related neuropeptide, urocortin II (Ucn II). Searches of the public human genome database identified a region with significant sequence homology to the CRF neuropeptide family. By using homologous primers deduced from the human sequence, a mouse cDNA was isolated from whole brain poly(A)(+) RNA that encodes a predicted 38-aa peptide, structurally related to the other known mammalian family members, CRF and Ucn. Ucn II binds selectively to the type 2 CRF receptor (CRF-R2), with no appreciable activity on CRF-R1. Transcripts encoding Ucn II are expressed in discrete regions of the rodent central nervous system, including stress-related cell groups in the hypothalamus (paraventricular and arcuate nuclei) and brainstem (locus coeruleus). Central administration of 1-10 microg of peptide elicits activational responses (Fos induction) preferentially within a core circuitry subserving autonomic and neuroendocrine regulation, but whose overall pattern does not broadly mimic the CRF-R2 distribution. Behaviorally, central Ucn II attenuates nighttime feeding, with a time course distinct from that seen in response to CRF. In contrast to CRF, however, central Ucn II failed to increase gross motor activity. These findings identify Ucn II as a new member of the CRF family of neuropeptides, which is expressed centrally and binds selectively to CRF-R2. Initial functional studies are consistent with Ucn II involvement in central autonomic and appetitive control, but not in generalized behavioral activation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.051626398

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the hypothalamus, PFOS caused upregulation of urocortin 2, an endogenous ligand for CRFR2 that suppresses feeding behavior and inhibits gastric emptying.

    “In the hypothalamus, PFOS caused upregulation of urocortin 2, an endogenous ligand for corticotropin releasing factor receptor 2 (CRFR2) that has been shown to suppress feeding behavior and inhibit gastric emptying”

    From A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior (2022) · cites this paper as Reyes et al., 2001

    The Abstract identifies urocortin II as a CRF-R2-selective ligand, and the Results report that central administration reduced nighttime food intake in rats. Our copy does not report that urocortin II inhibits gastric emptying. The PFOS upregulation is the citing authors’ finding, not the point this citation is offered to support. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [6]Behan D P, Grigoriadis D E, Lovenberg T, Chalmers D, Heinrichs S, Liaw C, De Souza E B. Mol Psychiatry. 1996;1:265–277. [PubMed] [Google Scholar]
  2. [10]Bittencourt J C, Vaughan J, Arias C, Rissman R A, Vale W W, Sawchenko P E. J Comp Neurol. 1999;415:285–312. [PubMed] [Google Scholar]
  3. [13]Simmons D M, Arriza J, Swanson L W. J Histotechnol. 1989;12:168–181. [Google Scholar]
  4. [14]Sawchenko P E, Cunningham E T, Jr, Mortrud M T, Gerfen C R. Methods Neurosci. 1990;3:247–260. [Google Scholar]

Cited by

Sorted by citations

Authors
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., & Sawchenko, P. E.
Affiliations
  • Scripps Research Institute (US)
  • Laboratory of Neuronal Structure and Function and Peptide Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037; and Department of Cell Biology, Scripps Research Institute, La Jolla, CA 92037
Corresponding author
Vale, W. W.
Venue
Proceedings of the National Academy of Sciences
Published
2001-02-27
Volume
98
Issue
5
Pages
2843-2848
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2095646540
Cited by
887
References
34
Citations by year
2026: 3 · 2025: 13 · 2024: 13 · 2023: 10 · 2022: 13 · 2021: 23 · 2020: 18 · 2019: 26 · 2018: 19 · 2017: 26 · 2016: 20 · 2015: 32 · 2014: 32 · 2013: 46 · 2012: 39
FWCI
26.36
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
  • Fondation pour la Recherche Médicale
  • National Institutes of Health (DK-26741)
  • National Institute of Diabetes and Digestive and Kidney Diseases (F32DK010135, DK 26741, P01DK026741, DK-10135)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
Keywords
urocortin II, corticotropin-releasing factor, CRF receptor 2, hypothalamic paraventricular nucleus, arcuate nucleus, locus coeruleus, Fos induction, nocturnal feeding, appetite regulation, autonomic regulation, neuroendocrine regulation, stress response
MeSH terms
CRF Receptor, Type 1, Amino Acid Sequence, Animals, Behavior, Animal, Cloning, Molecular, Corticotropin-Releasing Hormone, Cricetinae, Male, Molecular Sequence Data, RNA, Messenger, Polymerase Chain Reaction, CHO Cells, Proto-Oncogene Proteins c-fos, Rats, Sprague-Dawley, Sequence Homology, Amino Acid, Receptors, Corticotropin-Releasing Hormone, Rats, Urocortins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review